Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
US11746112B2 · kind B2 · utility
1Cited by
5References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 18, 2019 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Apr 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.